Drug-Induced Liver Injury: A Literature Review
Abstract
Drug-Induced liver injury (DILI) is a common harmful drug reaction of some medication which can cause the damage to liver cells, or might be a chance of death. In the western countries DILI is the main cause for acute liver failure. These reactions are very common because almost all drug regimens can cause injury to liver. Most of DILI cases are harmless and they get better after stopping the offending drug. These reactions are mainly due to some pharmacological remedies, traditional medications, herbal and nutritional supplements. Due to these harmful reactions, elevation is noticed in the liver enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphate, total bilirubin) 2N from its normal value. Drug-induced liver injury includes 1,000 of pharmacological remedies or more. Here, we review the maximum current literature, so the treatment includes timely diagnosis and removal of the doubtable medication is the key. This paper explains the different causes, pharmacological medications responsible for drug-induced liver injury, effect of covid-19 on liver injury and future perspective. It is important to be aware of and remove the suspected agent as soon as possible. There are no specific risk factors for DILI, but existing liver disease and genetic factors may be a priority for some people. Treatment of liver damage caused by drugs and herbs includes immediate drug withdrawal and supportive care aimed at alleviating unwanted symptoms. Main purpose of this paper is to deliver the info about the DILI, which are dose related, identification and consideration of disease.
Keywords: Drug-Induced liver injury (DILI), Pathophysiology, Diagnosis, Treatment, Risk factors and effect of covid-19 on liver injury.
Keywords:
Drug-Induced liver injury (DILI), Pathophysiology, Diagnosis, Treatment, Risk factors and effect of covid-19 on liver injuryDOI
https://doi.org/10.22270/jddt.v12i5.5674References
Matthew Hoffman M. picture of liver human anatomy. https://www.webmd.com/digestive-disorders/picture-of-the-liver
Clarke KA, Dew TP, Watson REB, et al. Green tea catechins and their metabolites in human skin before and after exposure to ultraviolet radiation. J Nutr Biochem. 2016; 27:203-210. https://doi.org/10.1016/j.jnutbio.2015.09.001
Mitra V, Metcalf J. Metabolic functions of the liver. Anaesth Intensive Care Med. 2012; 13(2):54-55. https://doi.org/10.1016/j.mpaic.2011.11.006
Johns H. Johns Hopkins. Johns Hopkins. https://doi.org/10.1353/book.80983
Cameron N, Henney A. Related Papers. Over Rim. Published online 2017; 191-199. https://doi.org/10.2307/j.ctt46nrzt.12
Benesic A. Drug-induced liver injury (DILI). MMW-Fortschritte der Medizin. 2019; 161(8):57-62. https://doi.org/10.1007/s15006-019-0458-z
Fisher K, Vuppalanchi R, Saxena R. Drug-induced liver injury. Arch Pathol Lab Med. 2015; 139(7):876-887. https://doi.org/10.5858/arpa.2014-0214-RA
Kaplowitz N. Drug-Induced Liver Injury. Clin Infect Dis. 2004; 38(SUPPL. 2). https://doi.org/10.1086/381446
Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014; 89(1):95-106. https://doi.org/10.1016/j.mayocp.2013.09.016
Meeting IC. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol. 1990; 11(2):272-276. https://doi.org/10.1016/0168-8278(90)90124-A
Stephens C, Andrade RJ, Lucena MI. Mechanisms of drug-induced liver injury. Curr Opin Allergy Clin Immunol. 2014; 14(4):286-292. https://doi.org/10.1097/ACI.0000000000000070
Hoofnagle JH, Björnsson ES. Drug-Induced Liver Injury - Types and Phenotypes. N Engl J Med. 2019; 381(3):264-273. https://doi.org/10.1056/NEJMra1816149
Raul J, Einar S, Gerd A. Drug-induced liver injury. 2019;5.
Morales M. L, Vélez L. N, Muñoz M. OG. Hepatotoxicity: A drug-induced cholestatic pattern. Rev Colomb Gastroenterol. 2016; 31(1):36-47. https://doi.org/10.22516/25007440.71
Mohankumar N, Ranjan MP, Kumari MA, MS. Drug-induced liver injury: Diagnosing (and treating) it early. Res J Pharm Technol. Published online 2015.
Kullak-Ublick GA. drug induced liver injury: recent advances in diagnosis and risk assessment. Published online 2017. https://doi.org/10.1136/gutjnl-2016-313369
Zhou Y, Yang L, Liao Z, He X, Zhou Y, Guo H. Epidemiology of drug-induced liver injury in China: A systematic analysis of the Chinese literature including 21 789 patients. Eur J Gastroenterol Hepatol. 2013; 25(7):825-829. https://doi.org/10.1097/MEG.0b013e32835f6889
Donati M, Conforti A, Lenti MC, et al. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy. Br J Clin Pharmacol. Published online 2016; 238-248. https://doi.org/10.1111/bcp.12938
Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004; 2(9):731-743. https://doi.org/10.1016/S1542-3565(04)00344-1
Licata A, Minissale MG, Calvaruso V, Craxì A. A focus on epidemiology of drug-induced liver injury: Analysis of a prospective cohort. Eur Rev Med Pharmacol Sci. 2017; 21(1):112-121.
Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of iceland. Gastroenterology. 2013; 144(7):1419-1425.e3. https://doi.org/10.1053/j.gastro.2013.02.006
Russmann S, Kullak-Ublick G, Grattagliano I. Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity. Curr Med Chem. 2009; 16(23):3041-3053. https://doi.org/10.2174/092986709788803097
Ye H. dissecting the molecular pathophisiology of drug-induced liver injury. Published online 2018. https://doi.org/10.3748/wjg.v24.i13.1373
J.S.Au. drug-induced liver injury-its pathology and evolving diagnostic tools. Published online 2011.
Stephens C, Lucena MI, Andrade J. and diagnosis. Published online 2019:715-728. https://doi.org/10.1002/9781119211419.ch47
stages of liver disease. Published 2021. https://kauveryhospital.com/blog/liver-diseases/5-stages-of-liver-disease/
Mack M. Inflammation and fibrosis. Matrix Biol. 2018; 68-69:106-121. https://doi.org/10.1016/j.matbio.2017.11.010
Li S, Hong M, Tan HY, Wang N, Feng Y. Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases. Oxid Med Cell Longev. 2016; 2016. https://doi.org/10.1155/2016/4234061
jill seladi-schulman. stages of liver failure. Published 2019. https://www.healthline.com/health/liver-failure-stages
Bataller R, Brenner D a. Science in medicine Liver fibrosis. J Clin Invest. 2005; 115(2):209-218. https://doi.org/10.1172/JCI24282
Šmíd V. Liver fibrosis. Vnitr Lek. 2020; 66(4):e36-e41. https://doi.org/10.36290/vnl.2020.078
Friedman SL. Hepatic fibrosis-Overview. Toxicology. 2008; 254(3):120-129. https://doi.org/10.1016/j.tox.2008.06.013
wen ce zhou.pdf.
cirrhosis 1.pdf.
Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol. 2011; 25(2):281-290. https://doi.org/10.1016/j.bpg.2011.02.009
Schuppan D, Afdhal NH. Seminar Liver cirrhosis. Lancet. 2008; 371:838-851. https://doi.org/10.1016/S0140-6736(08)60383-9
Yang YM, Kim SY, Seki E. Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets. Semin Liver Dis. 2019; 39(1):26-42. https://doi.org/10.1055/s-0038-1676806
Qi H, Xiao S, Shi R, et al. Enhanced Reader.pdf. Nature. 2018; 388:539-547.
Maluf D, Cotterell A, Clark B, Stravitz T, Kauffman HM, Fisher RA. Hepatic angiosarcoma and liver transplantation: Case report and literature review. Transplant Proc. 2005; 37(5):2195-2199. https://doi.org/10.1016/j.transproceed.2005.03.060
Sharma D, Subbarao G, Saxena R. Hepatoblastoma. Semin Diagn Pathol. 2017;34(2):192-200. https://doi.org/10.1053/j.semdp.2016.12.015
Melchionda F, Oncology P, Spreafico F, et al. LETTER TO THE EDITOR A Novel WT1 Mutation in Familial Wilms Tumor. Pediatr Blood Cancer. 2013; (February):1388-1389. https://doi.org/10.1002/pbc.24539
Hoti E, Adam R. Liver transplantation for primary and metastatic liver cancers. Transpl Int. 2008; 21(12):1107-1117. https://doi.org/10.1111/j.1432-2277.2008.00735.x
american cancer society. Published 2019. https://www.cancer.org/cancer/liver-cancer/about/what-is-liver-cancer.html
Giordano C, Rivas J, Zervos X. An update on treatment of drug-induced liver injury. J Clin Transl Hepatol. 2014; 2(2):74-79. https://doi.org/10.14218/JCTH.2014.00005
Lee william M, John senior R. diagnosis.pdf.
Devarbhavi H. Antituberculous drug-induced liver injury: current perspective. Trop Gastroenterol. 2011; 32(3):167-174.
Teschke R, Frenzel C. Drug induced liver injury: Do we still need a routine liver biopsy for diagnosis today? Ann Hepatol. 2014; 13(1):121-126. https://doi.org/10.1016/S1665-2681(19)30913-5
Indranil Mallick M. What Is Histopathology? Expertise, specialities, and training. Published 2020. https://www.verywellhealth.com/histopathology-2252152
Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut. 2009; 58(11):1555-1564. https://doi.org/10.1136/gut.2008.163675
Meeting IC. risk factors.pdf.
Martinez MA. impact of covid-19 in liver disease progression. Published online 2021
Published
Abstract Display: 1286 
PDF Downloads: 777 PDF Downloads: 65 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.